Download PDF
Endoscopy 2010; 42(6): 503-515
DOI: 10.1055/s-0029-1244208
Guidelines

© Georg Thieme Verlag KG Stuttgart · New York

European Society of Gastrointestinal Endoscopy (ESGE)Guideline: Prophylaxis of post-ERCP pancreatitis

J.-M.  Dumonceau1 , A.  Andriulli2 , J.  Deviere3 , A.  Mariani4 , J.  Rigaux3 , T.  H.  Baron5 , P.  A.  Testoni4
  • 1Service of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland
  • 2Division of Gastroenterology, Casa Sollievo Sofferemza Hospital, IRCCS, San Giovanni Rotondo, Italy
  • 3Departments of Gastroenterology and Hepato-Pancreatology, Erasme University Hospital, Brussels, Belgium
  • 4Division of Gastroenterology and Gastrointestinal Endoscopy, Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy
  • 5Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Medical Center, Rochester, Minnesota, USA
Further Information

Publication History

submitted 7 January 2010

accepted after revision 15 March 2010

Publication Date:
26 May 2010 (online)

Also available at
   Permissions and Reprints

Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Risk factors for post-ERCP pancreatitis (PEP) are both patient-related and procedure-related. Identification of patients at high risk for PEP is important in order to target prophylactic measures. Prevention of PEP includes administration of nonsteroidal inflammatory drugs (NSAIDs), use of specific cannulation techniques, and placement of temporary pancreatic stents. The aim of this guideline commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to provide practical, graded, recommendations for the prevention of PEP.

References

  • 1 Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines.  BMJ. 2001;  323 334-336
    PubMedGoogle Scholar
  • 2 Freeman M L, Nelson D B, Sherman S. et al . Complications of endoscopic biliary sphincterotomy.  N Engl J Med. 1996;  335 909-918
    CrossrefPubMedGoogle Scholar
  • 3 Choi C W, Kang D H, Kim G H. et al . Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.  Gastrointest Endosc. 2009;  69 e11-e18
    CrossrefPubMedGoogle Scholar
  • 4 Lee K T, Lee D H, Yoo B M. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis.  Pancreas. 2008;  37 445-448
    CrossrefPubMedGoogle Scholar
  • 5 Cotton P B, Lehman G, Vennes J. et al . Endoscopic sphincterotomy complications and their management: an attempt at consensus.  Gastrointest Endosc. 1991;  37 383-393
    CrossrefPubMedGoogle Scholar
  • 6 Bradley E L. A clinically based classification system for acute pancreatitis.  Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992: Arch Surg. 1993;  128 586-590
    CrossrefPubMedGoogle Scholar
  • 7 Testoni P A, Caporuscio S, Bagnolo F, Lella F. Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy.  Endoscopy. 1999;  31 131-136
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Bretthauer M, Seip B, Aasen S. et al . Carbon dioxide insufflation for more comfortable endoscopic retrograde cholangiopancreatography: a randomized, controlled, double-blind trial.  Endoscopy. 2007;  39 58-64
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Andriulli A, Loperfido S, Napolitano G. et al . Incidence rates of post-ERCP complications: a systematic survey of prospective studies.  Am J Gastroenterol. 2007;  102 1781-1788
    CrossrefPubMedGoogle Scholar
  • 10 Masci E, Mariani A, Curioni S, Testoni P A. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.  Endoscopy. 2003;  35 830-834
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Freeman M L, DiSario J A, Nelson D B. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.  Gastrointest Endosc. 2001;  54 425-434
    CrossrefPubMedGoogle Scholar
  • 12 Loperfido S, Angelini G, Benedetti G. et al . Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.  Gastrointest Endosc. 1998;  48 1-10
    CrossrefPubMedGoogle Scholar
  • 13 Masci E, Toti G, Mariani A. et al . Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.  Am J Gastroenterol. 2001;  96 417-423
    CrossrefPubMedGoogle Scholar
  • 14 Williams E J, Taylor S, Fairclough P. et al . Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.  Endoscopy. 2007;  39 793-801
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Harewood G C, Pochron N L, Gostout C J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla.  Gastrointest Endosc. 2005;  62 367-370
    CrossrefPubMedGoogle Scholar
  • 16 Norton I D, Gostout C J, Baron T H. et al . Safety and outcome of endoscopic snare excision of the major duodenal papilla.  Gastrointest Endosc. 2002;  56 239-243
    CrossrefPubMedGoogle Scholar
  • 17 Fazel A, Quadri A, Catalano M F, Meyerson S M, Geenen J E. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.  Gastrointest Endosc. 2003;  57 291-294
    CrossrefPubMedGoogle Scholar
  • 18 Smithline A, Silverman W, Rogers D. et al . Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients.  Gastrointest Endosc. 1993;  39 652-657
    CrossrefPubMedGoogle Scholar
  • 19 Tarnasky P R, Palesch Y Y, Cunningham J T. et al . Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.  Gastroenterology. 1998;  115 1518-1524
    CrossrefPubMedGoogle Scholar
  • 20 Andriulli A, Forlano R, Napolitano G. et al . Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.  Digestion. 2007;  75 156-163
    CrossrefPubMedGoogle Scholar
  • 21 Williams E J, Taylor S, Fairclough P. et al . Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice.  Gut. 2007;  56 821-829
    CrossrefPubMedGoogle Scholar
  • 22 Varadarajulu S, Kilgore M L, Wilcox C M, Eloubeidi M A. Relationship among hospital ERCP volume, length of stay, and technical outcomes.  Gastrointest Endosc. 2006;  64 338-347
    CrossrefPubMedGoogle Scholar
  • 23 Allison M C, Ramanaden D N, Fouweather M G, Davis D K, Colin-Jones D G. Provision of ERCP services and training in the United Kingdom.  Endoscopy. 2000;  32 693-699
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Hilsden R J, Romagnuolo J, May G R. Patterns of use of endoscopic retrograde cholangiopancreatography in a Canadian province.  Can J Gastroenterol. 2004;  18 619-624
    PubMedGoogle Scholar
  • 25 Colton J, Curran C. Quality indicators, including complications, of ERCP in a community setting: a prospective study.  Gastrointest Endosc. 2009;  70 457-467
    Google Scholar
  • 26 Rabenstein T, Roggenbuck S, Framke B. et al . Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?.  Gastrointest Endosc. 2002;  55 476-483
    CrossrefPubMedGoogle Scholar
  • 27 Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman G A. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.  Am J Gastroenterol. 1996;  91 1553-1557
    PubMedGoogle Scholar
  • 28 Testoni P A, Bagnolo F. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis.  Gastrointest Endosc. 2001;  53 33-39
    CrossrefPubMedGoogle Scholar
  • 29 Kapetanos D, Kokozidis G, Kinigopoulou P. et al . The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.  Hepato-Gastroenterol. 2007;  54 556-560
    PubMedGoogle Scholar
  • 30 Thomas P R, Sengupta S. Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level.  J Gastroenterol Hepatol. 2001;  16 923-926
    CrossrefPubMedGoogle Scholar
  • 31 Ito K, Fujita N, Noda Y. et al . Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.  World J Gastroenterol. 2007;  13 3855-3860
    CrossrefPubMedGoogle Scholar
  • 32 Dai H-F, Wang X-W, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.  Hepatobiliary Pancreat Dis Int. 2009;  8 11-16
    PubMedGoogle Scholar
  • 33 Elmunzer B, Waljee A, Elta G. et al . A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.  Gut. 2008;  57 1262
    CrossrefPubMedGoogle Scholar
  • 34 Zheng M-H, Xia H, Chen Y-P. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis.  Gut. 2008;  57 1632
    PubMedGoogle Scholar
  • 35 Bang U C, Nojgaard C, Andersen P K, Matzen P. Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis.  Aliment Pharmacol Ther. 2009;  29 1078-1085
    CrossrefPubMedGoogle Scholar
  • 36 Shao L M, Chen Q Y, Chen M Y, Cai J T. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis.  Dig Dis Sci. 2010;  55 1-7
    CrossrefPubMedGoogle Scholar
  • 37 Raty S, Sand J, Pulkkinen M, Matikainen M, Nordback I. Post-ERCP pancreatitis: reduction by routine antibiotics.  J Gastrointest Surg. 2001;  5 339-345; discussion 345
    CrossrefPubMedGoogle Scholar
  • 38 Andriulli A, Clemente R, Solmi L. et al . Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.  Gastrointest Endosc. 2002;  56 488-495
    CrossrefPubMedGoogle Scholar
  • 39 Andriulli A, Solmi L, Loperfido S. et al . Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.  Clin Gastroenterol Hepatol. 2004;  2 713-718
    CrossrefPubMedGoogle Scholar
  • 40 Arvanitidis D, Anagnostopoulos G K, Giannopoulos D. et al . Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.  J Gastroenterol Hepatol. 2004;  19 278-282
    CrossrefPubMedGoogle Scholar
  • 41 Benvenutti S, Zancanella L, Piazzi L. et al . Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomized placebo controlled multicenter study.  Dig Liv Dis. 2006;  38 S15
    PubMedGoogle Scholar
  • 42 Bordas J M, Toledo-Pimentel V, Llach J. et al . Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.  Gastrointest Endosc. 1998;  47 230-234
    CrossrefPubMedGoogle Scholar
  • 43 Persson B, Slezak P, Efendic S, Haggmark A. Can somatostatin prevent injection pancreatitis after ERCP?.  Hepatogastroenterology. 1992;  39 259-261
    PubMedGoogle Scholar
  • 44 Poon R T, Yeung C, Liu C L. et al . Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.  Gut. 2003;  52 1768-1773
    CrossrefPubMedGoogle Scholar
  • 45 Poon R T, Yeung C, Lo C M. et al . Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.  Gastrointest Endosc. 1999;  49 593-598
    CrossrefPubMedGoogle Scholar
  • 46 Saari A, Kivilaakso E, Schroder T. The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study.  Surg Res Comm. 1988;  2 271-278
    PubMedGoogle Scholar
  • 47 Arcidiacono R, Gambitta P, Rossi A. et al . The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.  Endoscopy. 1994;  26 715-718
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Duvnjak M, Supanc V, Simicevic V N. et al . Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.  Acta Med Croatica. 1999;  53 115-118
    PubMedGoogle Scholar
  • 49 Hardt P D, Kress O, Fadgyas T. et al . Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.  Eur J Med Res. 2000;  5 165-170
    PubMedGoogle Scholar
  • 50 Li Z S, Pan X, Zhang W J. et al . Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.  Am J Gastroenterol. 2007;  102 46-51
    CrossrefPubMedGoogle Scholar
  • 51 Manolakopoulos S, Avgerinos A, Vlachogiannakos J. et al . Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.  Gastrointest Endosc. 2002;  55 470-475
    CrossrefPubMedGoogle Scholar
  • 52 Sternlieb J M, Aronchick C A, Retig J N. et al . A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.  Am J Gastroenterol. 1992;  87 1561-1566
    PubMedGoogle Scholar
  • 53 Testoni P A, Bagnolo F, Andriulli A. et al . Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.  Aliment Pharmacol Ther. 2001;  15 965-972
    CrossrefPubMedGoogle Scholar
  • 54 Thomopoulos K C, Pagoni N A, Vagenas K A. et al . Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.  Gastrointest Endosc. 2006;  64 726-731
    CrossrefPubMedGoogle Scholar
  • 55 Cavallini G, Tittobello A, Frulloni L. et al . Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy – Italian Group.  N Engl J Med. 1996;  335 919-923
    CrossrefPubMedGoogle Scholar
  • 56 Manes G, Ardizzone S, Lombardi G. et al . Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.  Gastrointest Endosc. 2007;  65 982-987
    CrossrefPubMedGoogle Scholar
  • 57 Xiong G S, Wu S M, Zhang X W, Ge Z Z. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.  Braz J Med Biol Res. 2006;  39 85-90
    CrossrefPubMedGoogle Scholar
  • 58 Fujishiro H, Adachi K, Imaoka T. et al . Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.  J Gastroenterol Hepatol. 2006;  21 1065-1069
    CrossrefPubMedGoogle Scholar
  • 59 Tsujino T, Komatsu Y, Isayama H. et al . Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.  Clin Gastroenterol Hepatol. 2005;  3 376-383
    CrossrefPubMedGoogle Scholar
  • 60 Ueki T, Otani K, Kawamoto K. et al . Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.  J Gastroenterol. 2007;  42 161-167
    CrossrefPubMedGoogle Scholar
  • 61 Yoo J W, Ryu J K, Lee S H. et al . Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.  Pancreas. 2008;  37 366-370
    CrossrefPubMedGoogle Scholar
  • 62 Bai Y, Gao J, Shi X, Zou D, Li Z. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.  Pancreatology. 2008;  8 504-509
    CrossrefPubMedGoogle Scholar
  • 63 Zheng M, Bai J, Yuan B. et al . Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis.  BMC Gastroenterol. 2008;  8 6
    CrossrefPubMedGoogle Scholar
  • 64 Gorelick A, Barnett J, Chey W, Anderson M, Elta G. Botulinum toxin injection after biliary sphincterotomy.  Endoscopy. 2004;  36 170-173
    Article in Thieme ConnectPubMedGoogle Scholar
  • 65 Matsushita M, Takakuwa H, Shimeno N. et al . Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis.  J Gastroenterol. 2009;  44 71-75
    CrossrefPubMedGoogle Scholar
  • 66 Schwartz J J, Lew R J, Ahmad N A. et al . The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis.  Gastrointest Endosc. 2004;  59 179-184
    CrossrefPubMedGoogle Scholar
  • 67 Prat F, Amaris J, Ducot B. et al . Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.  Gastrointest Endosc. 2002;  56 202-208
    CrossrefPubMedGoogle Scholar
  • 68 Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.  Digestion. 1993;  54 105-111
    CrossrefPubMedGoogle Scholar
  • 69 Bai Y, Gao J, Zhang W, Zou D, Li Z. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis.  Aliment Pharmacol Ther. 2008;  28 557-564
    CrossrefPubMedGoogle Scholar
  • 70 Zheng M, Chen Y, Bai J. et al . Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.  Pancreas. 2008;  37 247-253
    CrossrefPubMedGoogle Scholar
  • 71 Andriulli A, Annese V. Risk of post-endoscopic retrograde cholangiopancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol.  Clin Gastroenterol Hepatol. 2008;  6 374-376
    CrossrefPubMedGoogle Scholar
  • 72 Katsinelos P, Kountouras J, Paroutoglou G. et al . Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.  Gastrointest Endosc. 2005;  62 105-111
    CrossrefPubMedGoogle Scholar
  • 73 Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.  World J Gastroenterol. 2006;  12 3751-3755
    PubMedGoogle Scholar
  • 74 Lavy A, Karban A, Suissa A. et al . Natural beta-carotene for the prevention of post-ERCP pancreatitis.  Pancreas. 2004;  29 e45-e50
    CrossrefPubMedGoogle Scholar
  • 75 Barkay O, Niv E, Santo E. et al . Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial.  Surg Endosc. 2008;  22 1971-1976
    CrossrefPubMedGoogle Scholar
  • 76 Rabenstein T, Fischer B, Wiessner V. et al . Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.  Gastrointest Endosc. 2004;  59 606-613
    CrossrefPubMedGoogle Scholar
  • 77 Deviere J, Le Moine O, Van Laethem J L. et al . Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.  Gastroenterology. 2001;  120 498-505
    CrossrefPubMedGoogle Scholar
  • 78 Dumot J A, Conwell D L, Zuccaro Jr G. et al . A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis.  Am J Gastroenterol. 2001;  96 2098-2102
    CrossrefPubMedGoogle Scholar
  • 79 Sherman S, Cheng C L, Costamagna G. et al . Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.  Pancreas. 2009;  38 267-274
    CrossrefPubMedGoogle Scholar
  • 80 Sherman S, Cheng C-L, Costamagna G. et al . Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.  Pancreas. 2009;  38 267-274
    CrossrefPubMedGoogle Scholar
  • 81 Kapetanos D, Kokozidis G, Christodoulou D. et al . A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.  Gastrointest Endosc. 2007;  66 513-518
    CrossrefPubMedGoogle Scholar
  • 82 Sherman S, Alazmi W M, Lehman G A. et al . Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.  Gastrointest Endosc. 2009;  69 462-472
    CrossrefPubMedGoogle Scholar
  • 83 van Westerloo D J, Rauws E A, Hommes D. et al . Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence.  Gastrointest Endosc. 2008;  68 246-254
    CrossrefPubMedGoogle Scholar
  • 84 Terruzzi V, Radaelli F, Meucci G, Minoli G. Is the supine position as safe and effective as the prone position for endoscopic retrograde cholangiopancreatography? A prospective randomized study.  Endoscopy. 2005;  37 1211-1214
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Tringali A, Mutignani M, Milano A, Perri V, Costamagna G. No difference between supine and prone position for ERCP in conscious sedated patients: a prospective randomized study.  Endoscopy. 2008;  40 93-97
    Article in Thieme ConnectPubMedGoogle Scholar
  • 86 Vandervoort J, Soetikno R M, Tham T CK. et al . Risk factors for complications after performance of ERCP.  Gastrointest Endosc. 2002;  56 652-656
    CrossrefPubMedGoogle Scholar
  • 87 Cheon Y K, Cho K B, Watkins J L. et al . Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.  Gastrointest Endosc. 2007;  65 385-393
    CrossrefPubMedGoogle Scholar
  • 88 George S, Kulkarni A A, Stevens G, Forsmark C E, Draganov P. Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a meta-analysis.  Dig Dis Sci. 2004;  49 503-508
    CrossrefPubMedGoogle Scholar
  • 89 Keswani R, Hovis R, Edmunowicz S. et al . Carbon dioxide (CO2) insufflation during ERCP for the reduction of post-procedure pain: preliminary results of a randomized, double-blind controlled trial.  Gastrointest Endosc. 2008;  67 AB107
    PubMedGoogle Scholar
  • 90 Maple J T, Keswani R N, Hovis R M. et al . Carbon dioxide insufflation during ERCP for reduction of postprocedure pain: a randomized, double-blind, controlled trial.  Gastrointest Endosc. 2009;  70 278-283
    CrossrefPubMedGoogle Scholar
  • 91 Cennamo V, Fuccio L, Zagari R M. et al . Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials.  Am J Gastroenterol. 2009;  104 2343-2350
    CrossrefPubMedGoogle Scholar
  • 92 Choudhary A, Puli S, Ibdah J, Bechtold M. Guidewire use for prevention of post ERCP pancreatitis: a meta-analysis of randomized controlled trials.  Gastrointest Endosc. 2009;  69 AB305
    PubMedGoogle Scholar
  • 93 Madhoun M, Te C, Stoner J, Maple J. Does wire-guided cannulation prevent post-ERCP pancreatitis? A meta-analysis.  Gastrointest Endosc. 2009;  69 AB132
    PubMedGoogle Scholar
  • 94 Cheung J, Tsoi K K, Quan W-L, Lau J YW, Sung J JY. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis.  Gastrointest Endosc. 2009;  70 1211-1219
    CrossrefPubMedGoogle Scholar
  • 95 Verma D, Kapadia A, Adler D G. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes.  Gastrointest Endosc. 2007;  66 283-290
    CrossrefPubMedGoogle Scholar
  • 96 Herreros de Tejada A, Calleja J L, Díaz G. et al . Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial.  Gastrointest Endosc. 2009;  70 700-709
    CrossrefPubMedGoogle Scholar
  • 97 Maeda S, Hayashi H, Hosokawa O. et al . Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement.  Endoscopy. 2003;  35 721-724
    Article in Thieme ConnectPubMedGoogle Scholar
  • 98 Ito K, Fujita N, Noda Y. et al . Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial.  Endoscopy. 2008;  40 (Suppl 1) A17
    Article in Thieme ConnectPubMedGoogle Scholar
  • 99 Nguyen-Tang T, Dumonceau J M. Double-guidewire technique for difficult bile duct cannulation: why not insert a prophylactic pancreatic stent?.  Gastrointest. Endosc 2010;  in press
    PubMedGoogle Scholar
  • 100 Iqbal S, Sharma P, Shah S. Role of double guide wire cannulation during ERCP.  Gastrointest Endosc. 2008;  67 AB158
    PubMedGoogle Scholar
  • 101 Ito K, Fujita N, Noda Y. et al . Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography.  World J Gastroenterol. 2008;  14 5595-5600; discussion 5599
    CrossrefPubMedGoogle Scholar
  • 102 Patel S, Torres V, Gross G. The early use of the double-wire technique to facilitate difficult biliary cannulation and its impact on post-ERCP pancreatitis.  Gastrointest Endosc. 2009;  69 AB159
    PubMedGoogle Scholar
  • 103 Gyökeres T, Duhl J, Varsányi M. et al . Double guide wire placement for endoscopic pancreaticobiliary procedures.  Endoscopy. 2003;  35 95-96
    Article in Thieme ConnectPubMedGoogle Scholar
  • 104 Cennamo V, Fuccio L, Repici A. et al . Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study.  Gastrointest Endosc. 2009;  69 473-479
    CrossrefPubMedGoogle Scholar
  • 105 Wang P, Li Z-S, Liu F. et al . Risk factors for ERCP-related complications: a prospective multicenter study.  Am J Gastroenterol. 2009;  104 31-40
    CrossrefPubMedGoogle Scholar
  • 106 Akaraviputh T, Lohsiriwat V, Swangsri J. et al . The learning curve for safety and success of precut sphincterotomy for therapeutic ERCP: a single endoscopist’s experience.  Endoscopy. 2008;  40 513-516
    Article in Thieme ConnectPubMedGoogle Scholar
  • 107 Fukatsu H, Kawamoto H, Harada R. et al . Quantitative assessment of technical proficiency in performing needle-knife precut papillotomy.  Surg Endosc. 2009;  23 2066-2072
    CrossrefPubMedGoogle Scholar
  • 108 Harewood G C, Baron T H. An assessment of the learning curve for precut biliary sphincterotomy.  Am J Gastroenterol. 2002;  97 1708-1712
    CrossrefPubMedGoogle Scholar
  • 109 Manes G, Di Giorgio P, Repici A. et al . An analysis of the factors associated with the development of complications in patients undergoing precut sphincterotomy: a prospective, controlled, randomized, multicenter study.  Am J Gastroenterol. 2009;  104 2412-2417
    CrossrefPubMedGoogle Scholar
  • 110 de Weerth A, Seitz U, Zhong Y. et al . Primary precutting versus conventional over-the-wire sphincterotomy for bile duct access: a prospective randomized study.  Endoscopy. 2006;  38 1235-1240
    Article in Thieme ConnectPubMedGoogle Scholar
  • 111 Tang S-J, Haber G B, Kortan P. et al . Precut papillotomy versus persistence in difficult biliary cannulation: a prospective randomized trial.  Endoscopy. 2005;  37 58-65
    Article in Thieme ConnectPubMedGoogle Scholar
  • 112 Yasuda I, Tomita E, Enya M, Kato T, Moriwaki H. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?.  Gut. 2001;  49 686-691
    CrossrefPubMedGoogle Scholar
  • 113 Baron T H, Harewood G C. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials.  Am J Gastroenterol. 2004;  99 1455-1460
    CrossrefPubMedGoogle Scholar
  • 114 Weinberg B M, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones.  Cochrane Database Syst Rev. 2006;  CD004890
    PubMedGoogle Scholar
  • 115 DiSario J A, Freeman M L, Bjorkman D J. et al . Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.  Gastroenterology. 2004;  127 1291-1299
    CrossrefPubMedGoogle Scholar
  • 116 Attasaranya S, Cheon Y, Vittal H. et al . Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series.  Gastrointest Endosc. 2008;  67 1046-1052
    CrossrefPubMedGoogle Scholar
  • 117 Ersoz G, Tekesin O, Ozutemiz A O, Gunsar F. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract.  Gastrointest Endosc. 2003;  57 156-159
    CrossrefPubMedGoogle Scholar
  • 118 Maydeo A, Bhandari S. Balloon sphincteroplasty for removing difficult bile duct stones.  Endoscopy. 2007;  39 958-961
    Article in Thieme ConnectPubMedGoogle Scholar
  • 119 Minami A, Hirose S, Nomoto T, Hayakawa S. Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy.  World J Gastroenterol. 2007;  13 2179-2182
    CrossrefPubMedGoogle Scholar
  • 120 Misra S P, Dwivedi M. Large-diameter balloon dilation after endoscopic sphincterotomy for removal of difficult bile duct stones.  Endoscopy. 2008;  40 209-213
    Article in Thieme ConnectPubMedGoogle Scholar
  • 121 Heo J H, Kang D H, Jung H J. et al . Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones.  Gastrointest Endosc. 2007;  66 720-726; quiz 768, 771
    CrossrefPubMedGoogle Scholar
  • 122 Kawamoto M, Geenen J, Omari T. et al . Sleeve sphincter of Oddi (SO) manometry: a new method for characterizing the motility of the sphincter of Oddi.  J Hepatobiliary Pancreat Surg. 2008;  15 391-396
    CrossrefPubMedGoogle Scholar
  • 123 Frenz M B, Wehrmann T. Solid state biliary manometry catheter: impact on diagnosis and post-study pancreatitis.  Curr Gastroenterol Rep. 2007;  9 171-174
    CrossrefPubMedGoogle Scholar
  • 124 Craig A G, Omari T, Lingenfelser T. et al . Development of a sleeve sensor for measurement of sphincter of Oddi motility.  Endoscopy. 2001;  33 651-657
    Article in Thieme ConnectPubMedGoogle Scholar
  • 125 Sherman S, Troiano F P, Hawes R H, Lehman G A. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter.  Gastrointest Endosc. 1990;  36 462-466
    CrossrefPubMedGoogle Scholar
  • 126 Draganov P, Kowalczyk L, Forsmark C. Prospective trial comparing solid-state catheter and water-perfusion triple-lumen catheter for sphincter of Oddi manometry done at the time of ERCP.  Gastrointest Endosc. 2009;  70 92-95
    CrossrefPubMedGoogle Scholar
  • 127 Wehrmann T, Stergiou N, Schmitt T, Dietrich C F, Seifert H. Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with the perfusion manometry technique.  Endoscopy. 2003;  35 472-477
    Article in Thieme ConnectPubMedGoogle Scholar
  • 128 Sherman S, Hawes R H, Troiano F P, Lehman G A. Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter.  Gastrointest Endosc. 1992;  38 347-350
    CrossrefPubMedGoogle Scholar
  • 129 Singh P, Das A, Isenberg G. et al . Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.  Gastrointest Endosc. 2004;  60 544-550
    CrossrefPubMedGoogle Scholar
  • 130 Sofuni A, Maguchi H, Itoi T. et al . Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.  Clin Gastroenterol Hepatol. 2007;  5 1339-1346
    CrossrefPubMedGoogle Scholar
  • 131 Chahal P, Tarnasky P, Petersen B. et al . Short 5Fr vs long 3Fr pancreatic stents in patients at high risk for post- endoscopic cholangiopancreatography pancreatitis.  Clin Gastroenterol Hepatol. 2009;  7 834-839
    CrossrefPubMedGoogle Scholar
  • 132 Fehmi S MA, Schoenfeld P S, Scheiman J M. et al . 5 Fr prophylactic pancreatic stents are easier to place and require fewer guide wires than 3 Fr stents.  Gastrointest Endosc. 2008;  67 AB328-AB329
    PubMedGoogle Scholar
  • 133 Smith M T, Sherman S, Ikenberry S O, Hawes R H, Lehman G A. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.  Gastrointest Endosc. 1996;  44 268-275
    Google Scholar
  • 134 Das A, Singh P, Sivak M V, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.  Gastrointest Endosc. 2007;  65 960-968
    CrossrefPubMedGoogle Scholar
  • 135 Freeman M L, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.  Gastrointest Endosc. 2004;  59 8-14
    CrossrefPubMedGoogle Scholar
  • 136 Brackbill S, Young S, Schoenfeld P, Elta G. A survey of physician practices on prophylactic pancreatic stents.  Gastrointest Endosc. 2006;  64 45-52
    CrossrefPubMedGoogle Scholar
  • 137 Dumonceau J M, Rigaux J, Kahaleh M. et al . Prophylaxis of post-ERCP pancreatitis: a practice survey.  Gastrointest Endosc. 2010;  71 934-939
    CrossrefPubMedGoogle Scholar

J.-M. DumonceauMD, PhD 

Division of Gastroenterology and Hepatology
Geneva University Hospitals

rue Micheli-du-Crest 24
1205 Geneva
Switzerland

Fax: +41-22-3729366

Email: jmdumonceau@hotmail.com